New biochemical markers of bone resorption in the study of postmenopausal osteoporosis

Clinica Chimica Acta

Volumn 265, Issue 2, 1997, Pages 225-234

  De La Piedra, Concepción ^a   Traba, Maria Luisa ^a   Dominguez Cabrera, Casimira ^b   Sosa Henríquez, Manuel ^b  

^a Fund Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Bone markers; C telopeptide; Deoxypyridinoline; N telopeptide; Postmenopausal osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN DERIVATIVE; DEOXYPYRIDINOLINE; PYRIDINOLINE;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; AGING; AMINO ACIDS; BIOLOGICAL MARKERS; BONE RESORPTION; CALCIUM; COLLAGEN; COLLAGEN TYPE I; CREATININE; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PYRIDINES; SENSITIVITY AND SPECIFICITY;

EID: 0030881517     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00131-9     Document Type: Article

References (16)

1. Garnero P, Sornay Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49.
2. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 1993;3:255-60.
3. Guerrero R, Díaz Martín MA, Díaz-Diego EM, Turbí C, Rapado A, De la Piedra C. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis. Osteoporosis Int 1996;6:297-302.
4. Seyedin SM, Kung V, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635-41.
5. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643-9.
6. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;39:635-40.
7. Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-8.
8. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
9. Delmas PD. Biochemical markers of bone remodeling in osteoporosis. In: Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delmas PD, editors. Osteoporosis 1996. Amsterdam: Elsevier, 1996:191-204.
10. Eyre D. Editorial: New biomarkers of bone resorption. J Clin Endocrinol Metab 1992;74:470A-B.
11. Garnero P Gineyts E, Arbault P, Christiansen C, Delmas PD. Different effects of biphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.
12. Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994;54:381-4.
13. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
14. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int 1994;54:26-9.
15. Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 1996;125:360-8.
16. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366-71.